Trial Bank
Overview
3,133 trials match
Observational studies (…) are hidden. Tick 'Include observational studies' to show them.
The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson i
The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson in Patients With Multiple Sclerosis
MSRelapsing MSNot a drug-phase studyCompletedDeniz Çakır · 2021 · 44 participants
Individualised Cryoneurolysis to Treat Pain in the Context of Spastici
Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
MSMS (type not specified)Phase 4RecruitingOxford University Hospitals NHS Trust · 2025 · 50 participants
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegen
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
MSRelapsing MSNot a drug-phase studyRunning, not recruitingIRCCS Centro Neurolesi Bonino Pulejo · 2026 · 300 participants
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sc
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
MSMS (type not specified)Phase 2Recruitingpegsebrenatide · Johns Hopkins University · 2026 · 120 participants
A Study of Subcutaneously Administered RO7845860 in Participants With
A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis
MSRelapsing and progressivePhase 1Not yet recruitingHoffmann-La Roche · 2026 · 85 participants
Virtual Reality Versus Mental Practice On Balance And Gait In Patients
Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis
MSRelapsing MSNot a drug-phase studyRecruitingCairo University · 2026 · 54 participants
A study to investigate long-term safety and tolerability of frexalimab
A study to investigate long-term safety and tolerability of frexalimab in participants with multiple sclerosis
MSRelapsing MSPhase 3Not yet recruitingfrexalimab · Sanofi-Aventis Recherche & Developpement · 2027 · 957 participants
Improving brain health in multiple sclerosis through aerobic exercise
Improving brain health in multiple sclerosis through aerobic exercise
MSMS (type not specified)Ongoing (inferred)2026 · 84 participants
Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subj
Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication
MSMS (type not specified)Not a drug-phase studyCompletedIstituto Auxologico Italiano · 2020 · 15 participants
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe D
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
MSMS (type not specified)Phase 1Phase 2Running, not recruitingDuke University · 2023 · 9 participants
A Study of Orelabrutinib in Patients With Secondary Progressive Multip
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
MSRelapsing and progressivePhase 3Recruitingorelabrutinib · Zenas BioPharma (USA), LLC · 2026 · 990 participants
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multipl
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
MOGADMSNMOSDNot a drug-phase studyNot yet recruitingInstitut National de la Santé Et de la Recherche Médicale, France · 2026 · 500 participants
Safety and Efficacy of Secukinumab Versus Mycophenolate Mofetil in Rel
Safety and Efficacy of Secukinumab Versus Mycophenolate Mofetil in Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (SMART)
MOGADPhase 3Not yet recruitingsecukinumab · Chinese PLA General Hospital · 2026 · 130 participants
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasma
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
MSMS (type not specified)Phase 1Completedferumoxytol · National Institute of Neurological Disorders and Stroke (NINDS) · 2015 · 14 participants
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCo
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect
MSRelapsing and progressiveNot a drug-phase studyRunning, not recruitingAd scientiam · 2023 · 336 participants
Motor Learning in Health and Movement Disorders: Role of Physical Acti
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
MSNMOSDNot a drug-phase studyRecruitingIRCCS Centro Neurolesi Bonino Pulejo · 2024 · 150 participants
A Study of Orelabrutinib in Patients With Primary Progressive Multiple
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
MSProgressive MSPhase 3Recruitingorelabrutinib · Zenas BioPharma (USA), LLC · 2026 · 705 participants
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multip
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
MSRelapsing MSNot a drug-phase studyRecruitingCentre Hospitalier Universitaire de Nīmes · 2025 · 84 participants
Wearable Focal Vibration Therapy on Upper Extremity Function of People
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
MSRelapsing MSNot a drug-phase studyRecruitingUniversity of Florida · 2026 · 15 participants
Treatment of Memory Retrieval Impairments in MS With HDtDCS to the LIF
Treatment of Memory Retrieval Impairments in MS With HDtDCS to the LIFG in a Placebo Controlled Trial
MSRelapsing MSNot a drug-phase studyNot yet recruitingThe University of Texas at Dallas · 2026 · 80 participants
A comparison of skin temperature changes around the knee when using cr
A comparison of skin temperature changes around the knee when using cryo-compression devices
NMOSDNot a drug-phase studyCompleted (inferred)2022 · 32 participants
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
MSRelapsing MSPhase 4Running, not recruitingfingolimod · Novartis Pharmaceuticals · 2020 · 14 participants
Impact of a Structured Wellness Behavioral Intervention on Quality of
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
NMOSDNot a drug-phase studyRecruitingIcahn School of Medicine at Mount Sinai · 2025 · 20 participants
MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integratio
MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
MSMS (type not specified)Not a drug-phase studyCompletedAd scientiam · 2025 · 62 participants
HOBSCOTCH-MS-Efficacy Trial
HOBSCOTCH-MS-Efficacy Trial
MSProgressive MSNot a drug-phase studyRecruitingDartmouth-Hitchcock Medical Center · 2025 · 125 participants
About this data
Where the data comes from
ClinicalTrials.gov, the EU Clinical Trials Register, ISRCTN, ChEMBL and Europe PMC, combined into the MSFrontier trial bank.
How it is collected
Registry records are collected automatically, duplicate records across registries are merged, and treatments, phases and populations are tagged by software from the registry data. When an error is reported, we fix the rule so the fix applies to every trial, and log it in the Corrections log.
Last update
Trial bank updated recently. Sources and corrections